US 10,220,019 B2Granted

Method for treating pulmonary fibrosis comprising application of dimethylamino micheliolide

AssigneesTianjin International Joint Academy of Biotechnology & Medicine, Accendatech

InventorsTao Sun, Yue Chen, Cheng Yang, Honggang Zhou, Huijuan Liu, Yanrong Liu, Jing Wang, Chengyu Zhang, Qiang Zhang, Xiangming Zhang, Yuan Qin, Xueshuang Jing

Life of this patent

Estimating the term…

Abstract

The present invention provides an application of a dimethylamino micheliolide for preparing a pharmaceutical product for treating pulmonary fibrosis.

Claims9

Dependent claims

A method for treating pulmonary fibrosis, comprising an application of a dimethylamino micheliolide in preparing a pharmaceutical product, wherein the dimethylamino micheliolide has a molecular structural formula of:

Dependencies are inferred from the claim text.

Facts

Application: 15/748,624Filed 28 Jan 2016
Published: US 2019/0000798 A13 Jan 2019
Granted: 5 Mar 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 31/365
Having oxygen as the only ring hetero atom, e.g. fungichromin: lactones
A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/0073
Pulmonary tract; Aromatherapy: sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Family

US 2019/0000798 A1Pre-grant publication · published 3 Jan 2019
US 10,220,019 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results